No endorsement of Task Force findings or recommendations on the part of these individuals or their employers is necessarily implied.
|Beth Bortz||Virginia Center for Health Innovation|
|Diana Buist, PhD||Kaiser Permanente Washington Health Research Institute|
|Marcy Carty, MD||Blue Cross Blue Shield of Massachusetts|
|Gwen Darien||Patient Advocate Foundation|
|Robert Dressler||Christiana Care Health System|
|Samanntha DuBridge||Hewlett Packard Enterprise|
|Nancy Giunto||Washington Health Alliance|
|Ira Klein, MD||Janssen|
|Cheryl Larson||Midwest Business Group on Health|
|Claire Levitt||City of New York|
|Larry McNeely||National Coalition on Health Care|
|Stephen Moorehead||Blue Cross Blue Shield of Massachusetts|
|Anikia Nelson, MD||Milliman|
|Troy Ross||Mid‐America Coalition on Health Care|
|Dana Gelb Safran, ScD||Blue Cross Blue Shield of Massachusetts|
|Bruce Sherman||Employers Health Coalition|
|Lauren Vela||Pacific Business Group on Health|
|Mark Weinstein||Independent Colleges and Universities Benefits Association|
Clifford Goodman, PhD, of The Lewin Group serves as moderator.
The Task Force is led by Michael Chernew, PhD, and A. Mark Fendrick, MD.
Financial support for Task Force activities has been provided by Amgen, Janssen, Pfizer, Sanofi and PhRMA.